DATATRAK Introduces Transformative eClinical Enterprise Applications
- Includes Real-Time Cross-Study Reporting
- Simplifies Management of Clinical Research
CLEVELAND, Dec. 17, 2014 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced the introduction of unprecedented enterprise-wide eClinical tools to simplify clinical research management. Amongst other improvements, three significant new applications have been added to the DATATRAK ONE® Unified Experience™.
Cross-Study Managers fulfill the unique information needs of each research professional, whether reporting at an individual or cross-study level, with instant access to real-time enterprise-wide data. With flexible reporting capabilities across over 100 fields, users can tailor reports to address their precise requirements. The Cross-Study Manager is the latest addition to the full set of online Data Management tools available from DATATRAK.
The Scheduler automates the delivery of the right information to the right person at the right time. Users can create a timeline of future actions, including the delivery of Standard and Ad-hoc reports, Exports and Sub-set Exports and Imports at the study or enterprise-wide level.
With File Versioning, trial teams can improve the quality of data with instant access to current and previous versions of files across all studies on the DATATRAK ONE® Unified Experience™. Users facilitate collaboration in the cloud with a single location to view study documentation.
"Simplifying clinical trial management, using real-time data at the trial or enterprise level, is uniquely available through the latest release of our unified eClinical® platform: DATATRAK ONE® Unified Experience™. Putting the power of the data into the hands of the users, from CEOs to Data Managers, enables on-the-spot reporting and decision making. Every CEO will see the immediate benefit of these applications," said Laurence P. Birch, DATATRAK Chairman and CEO. "Each of the applications in our latest release, particularly the Cross-Study Manager, demonstrates the fundamental difference between our unified eClinical® platform and integrated solutions from our competitors – real-time instant data views across trials."
These applications provide enterprise-wide functionality that removes complexities in the clinical research process, demonstrating the advantages of a single data source available from the DATATRAK ONE® Unified Experience™.
"It's not just the enhancements in this release that demonstrate the power of our Unified eClinical® platform," continued Birch. "It is the way we simplify the implementation of the modules to our clients. It's effortless. Each trial has the option to turn on each feature at the click of a button. There are no additional steps required. That means no data moves, no upgrades to install at the trial level or any trial specific downtime. It is just that simple with the DATATRAK ONE® Unified eClinical® platform."
To find out more about the latest release from DATATRAK, visit us online or request a demo.
Join DATATRAK Thought Leaders:
Tweet: DATATRAK announces enterprise wide functionality including cross-study real-time data reporting and more http://bit.ly/1yWSX9u
About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering unified eClinical® solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Preclinical and Phase I - Phase IV drug and device studies in multiple languages throughout the world. DATATRAK is located in Cleveland, Ohio; Bryan, Texas; Cary (RTP), North Carolina; Chicago, Illinois; and the UK. For more information, visit http://www.datatrak.com.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements
are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on November 13, 2014 announcing its results for the third quarter period ending September 30, 2014. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/datatrak-introduces-transformative-eclinical-enterprise-applications-300010921.html
SOURCE DATATRAK International, Inc.
Share this article